Novel 23-Hydroxybetulinic Acid Derivatives: Semi-Synthesis and Antibacterial Activity

Zhongde Xie,Xuelian Dai,Liqing Wang
DOI: https://doi.org/10.1134/s1070363224100219
2024-11-27
Russian Journal of General Chemistry
Abstract:A novel series of 23-hydroxybetulinic acid derivatives were designed and synthesized, in which some compounds displayed good antibacterial activity with MIC values of 4–16 μg/mL against gram-positive bacteria and moderate inhibitory activity (16–32 μg/mL) against gram-negative bacteria. 23- O -6-Aminohexyl[3,2- b ]pyrazine oleanan-28,19β-lactone demonstrated the most potent antibacterial activity against S. aureus , B. subtilis , E. coli , and P. aeruginosa with MICs ranging from 4 to 16 μg/mL. Additional testing against drug-resistant bacteria (MRSA and K. pneumonia ) showed 23- O -6-aminohexyl[3,2- b ]pyrazine oleanan-28,19β-lactone also possessed good antibacterial activity (4–32 μg/mL). In addition, this lactone interacted effectively with cell membranes, posed negligible cytotoxicity to mammalian cells, and rapidly curbed the growth of MRSA and E. coli , while not significantly enhancing bacterial resistance. The subsequent assay of bactericidal time-kill kinetics revealed that 23- O -6-aminohexyl[3,2- b ]pyrazine oleanan-28,19β-lactone showed excellent bactericidal activity against MRSA at 3MIC (> 6 log 10 CFU/mL reduction) after 9 h, whereas the positive control group only demonstrated inhibitory activity. Additionally, study of drug-likeness properties suggest that these molecules may have drug-likeness characteristics, potentially improving membrane absorption and bioavailability.
chemistry, multidisciplinary
What problem does this paper attempt to address?